EXHIBIT 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

Reviva Pharmaceuticals Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

   

Security
Type

  

Security

Class
Title

  

Fee
Calculation
or Carry
Forward
Rule

  

Amount

Registered

(1)

    

Proposed
Maximum

Offering
Price Per
Unit (2)

    

Maximum
Aggregate
Offering
Price

    

Fee Rate

    

Amount of
Registration
Fee

  

Fees to Be
Paid

  

Equity

  

Common

Stock,

par value

$0.0001

per share

  

Other

     4,743,083     $ 1.635     $ 7,754,940.71       0.00011020     $ 854.60  
   

Total Offering Amounts

           $ 7,754,940.71             $ 854.60  
   

Total Fees Previously Paid

                           $ 0  
   

Total Fee Offsets

                           $ 0  
   

Net Fee Due

                           $ 854.60  

 

(1)

Pursuant to Rule 416 under the Securities Act, there is also being registered hereby such indeterminate number of additional shares of common stock as may be issued or issuable because of stock splits, stock dividends stock distributions, and similar transactions.

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended. The proposed maximum offering price per share and proposed maximum aggregate offering price are based upon the average of the high $1.71 and low $1.56 sale prices of our common stock on September 30, 2022, as reported on the Nasdaq Capital Market.